Adverse Effects

Contributing journals to this collection:
JAMA & Archives Journals

Citations 371-380 of 1622 total displayed.

Past content

Editor's Correspondence
Factors in Warfarin Therapy Discontinuation

Christopher John Boos; Howard J. Marshall
Arch Intern Med 2008; 168: 1932-a. [Extract] [Full text] [PDF]  

Editor's Correspondence
Warfarin Therapy Adjustment for Oral Surgery Is an Unnecessary Risk

Duncan Bayne; Peter A. Brennan
Arch Intern Med 2008; 168: 1932. [Extract] [Full text] [PDF]  

Editor's Correspondence
Factors in Warfarin Therapy Discontinuation—Reply

David Garcia; Elaine Hylek
Arch Intern Med 2008; 168: 1933. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Time for "the Talk"—Again: Seniors Need Information on Sexual Health

Bridget M. Kuehn
JAMA 2008; 300: 1285-1287. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Alcohol Dependence Drug Prompts Warning

Mike Mitka
JAMA 2008; 300: 1289. [Extract] [Full text] [PDF]  

Original Investigations
Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin: An Assessment of Safety and Pharmacodynamics: The DIRECT Study

James Douketis; Deborah Cook; Maureen Meade; Gordon Guyatt; William Geerts; Yoanna Skrobik; Martin Albert; John Granton; Paul Hébert; Guiseppe Pagliarello; John Marshall; Robert Fowler; Andreas Freitag; Christian Rabbat; David Anderson; Nicole Zytaruk; Diane Heels-Ansdell; Mark Crowther; for the Canadian Critical Care Trials Group
Arch Intern Med 2008; 168: 1805-1812. [Abstract] [Full text] [PDF]  

Editor's Correspondence
Fluoroquinolone Use With No Increase in Culture-Negative Tuberculosis

Minoru Matsushima; Shungo Yamamoto; Kentaro Iwata; David G. Gremillion
Arch Intern Med 2008; 168: 1824-a-1825-a. [Extract] [Full text] [PDF]  

Editor's Correspondence
Fluoroquinolone Use With No Increase in Culture-Negative Tuberculosis—Reply

Timothy R. Sterling
Arch Intern Med 2008; 168: 1825. [Extract] [Full text] [PDF]  

Letters
Clopidogrel Treatment and the MEND-CABG II Trial—Reply

John H. Alexander; Stephen J. Ellis; Jean-Claude Tardif
JAMA 2008; 300: 1021-a-1022-a. [Extract] [Full text] [PDF]  

Letters
Clopidogrel Treatment and the MEND-CABG II Trial

Jaewon Oh; Namki Hong; Seok-Min Kang
JAMA 2008; 300: 1021. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163